Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Immunohistochemistry Study of the Expression of Glycine/ Serine Pathway Molecules in Solid Tumors

NCT02103920 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT02103920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02103920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Immunohistochemistry Study of the Expression of Glycine/ Serine Pathway Molecules in Solid Tumors
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2011
Completion date
Not reported
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor cancer